Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Royalty Pharma, Open Text and VICI Properties have rewarded shareholders for decades and recently announced dividend increases. These companies currently offer dividend yields of around 3-5%.
Royalty Pharma
Royalty Pharma (NASDAQ:RPRX) is a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in identifying, evaluating and acquiring royalties on various biopharmaceutical therapies.
The company has consistently increased its dividends since 2020. According to the company's most recent dividend hike announcement on Jan. 19, its board of directors raised the quarterly dividend by 5% to $0.21 per share or $0.84 annualized. The dividend yield on the stock currently stands at 3.20%.
Royalty Pharma’s annual revenue (as of Sept. 30) stood at $2.3 billion. The company’s most recent earnings announcement on Nov. 6 posted Q3 2024 revenues of $565 million, missing the consensus estimate of $696.10 million and an EPS of $1.04, beating the consensus of $0.93.
Check out this article by Benzinga, highlighting the views of Wall Street’s most accurate analysts on three health care stocks with over 3% dividend yields.
Open Text
Open Text Corporation (NASDAQ:OTEX) provides information management products and services. The company offers content services, including content collaboration, intelligent capture, records management, collaboration, e-signatures and archiving. It operates an experience cloud platform that provides customer experience and web content management, digital asset management, customer analytics, AI and insights, e-discovery, digital fax, omnichannel communications, secure messaging and voice of the customer.
Open Text has increased its dividend every year since 2014. According to its most recent dividend announcement on Aug. 1, it raised the quarterly dividend by 5% to $0.2625 per share, equal to $1.05 annualized. The dividend yield on the stock is 3.50%.
The company’s annual revenue (as of Sept. 30) stood at $5.6 billion. On Oct. 31, the company reported its Q1 2025 earnings, posting revenues of $1.27 billion, slightly missing the consensus estimate of $1.28 billion and an EPS of $0.93, above the consensus of $0.80.
VICI Properties
VICI Properties (NYSE:VICI) is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas, three of the most iconic entertainment facilities on the Las Vegas Strip.
VICI Properties has consistently increased its dividends for the last six years. As per its most recent dividend hike announcement on Sept. 5, it raised the quarterly dividend by 4.2% to $0.4325 per share, which is equal to the annualized figure of $1.73. The current yield on the dividend is 5.34%.
VICI Properties’ annual revenue (as of Sept. 30) stood at $3.8 billion. According to the company’s Q3 2024 earnings announcement on Oct. 31, it posted revenues of $964.67 million and an EPS of $0.57. Both figures were above the consensus estimates.
Check out this article by Benzinga for five analysts' insights on VICI Properties.
Royalty Pharma, Open Text and VICI Properties are good choices for investors seeking reliable passive income. Their dividend yields of around 3-5% and long history of consistent hikes make them attractive to income-focused investors.
This article How Royalty Pharma, Open Text And VICI Properties Can Put Cash In Your Pocket originally appeared on Benzinga.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.